Skip to main navigation Skip to search Skip to main content

The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients

  • J. A. Burger
  • , A. Ochs
  • , K. Wirth
  • , D. P. Berger
  • , R. Mertelsmann
  • , R. Engelhardt
  • , M. Roessle
  • , K. Haag

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The increase in portal vascular resistance is a significant complication of metastatic disease to the liver or locally advanced cancer, e.g., biliary cancer. Patients and methods: This paper describes the successful palliative treatment of two cancer patients with portal hypertension presenting with the symptoms of tense ascites, mesenteric congestion, and severe variceal bleeding. By creating a stent tract between a hepatic vein and a main branch of the portal vein and/or by placing an extendable stent into the portal vein, the transjugular intrahepatic portosystemic stent-shunt (TIPS) technique was used to decompress the portovascular system. Results: The TIPS-technique offers a new, safe and effective palliation for malignant portal hypertension. In both patients, the symptoms of the portal hypertension disappeared after the procedure. This was accompanied by a significant improvement of the patients performance status, allowing an early ambulation. Conclusion: Our findings demonstrate the feasibility and effectiveness of the TIPS procedure as a minimal invasive treatment for portal vein decompression in selected tumor patients.

Original languageEnglish (US)
Pages (from-to)200-202
Number of pages3
JournalAnnals of Oncology
Volume8
Issue number2
DOIs
StatePublished - Feb 1997
Externally publishedYes

Keywords

  • malignant portal hypertension
  • portal vein stent
  • transjugular intrahepatic portosystemic stent-shunt procedure (TIPS)

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients'. Together they form a unique fingerprint.

Cite this